Dementia Moonshot Report: Research Priorities and Costs (Alzheimer’s Research UK)

Summary

Alzheimer’s Research UK (ARUK) have released a brief report on six research priorities, which are:

1. Achieving earlier detection of diseases which may cause dementia, (ideally by 10-15 years), to enhance development of new treatments / interventions for people most at risk of developing dementia.
2. Developing novel validated targets in early drug development to maximise chances of successful clinical trials.
3. Ensuring the UK is the best place to conduct clinical dementia research.
4. Expanding the research infrastructure; maintaining the UK’s position as a world leader in dementia research.
5. Improving dementia risk reduction and prevention, in the context of multi-morbidities.
6. Developing robust prevalence data for dementia; increasing knowledge of the societal impact of dementia.

The overall aim is to deliver life-changing treatment(s) for dementia by doubling research funding and investing in trials for new treatments.

Full Text Link

Reference

Delivering the dementia moonshot: a plan to find life-changing treatments. Cambridge: Alzheimer’s Research UK, January 2020.

An earlier related report:

Full Text Link

Reference

No time to lose: an action plan for dementia. Cambridge: Alzheimer’s Research UK, September 2018.